Session 3: CHILD Study: Gene-environment, Epigenetics & Microbiome

Research leaders in these vital areas of ground-breaking CHILD research will share key findings and future plans.

Interaction of the environment and the microbiome

Speaker: Dr. Hind Sbihi

The CHILD study has collected a wealth of information on the outdoor environment and its interaction with the health of the children participating in the Study. Dr. Sbihi will describe ongoing analyses, within CHILD, of the environment and its interaction with the microbiome.

Gene-environment impacts on lung health & asthma risk

Speaker: Dr. Qingling Duan

Gene risk scores, in the context of the environment, will become increasingly important the more the healthcare system moves toward implementing personalized care. Dr. Duan will described the work accomplished to date in this area within the CHILD Study, noting the unique data of relevance that CHILD has collected (such as data on ethnicity).

Indoor exposures & the microbiome

Speaker: Dr. Anita Kozyrskyj

Dr. Kozyrskyj will discuss research findings generated from CHILD data on the impact of the indoor environment on health outcomes, with a possible mechanism through the gut microbiome, focusing in particular on the impact of household pets and cleaning products.

An epigenetic lens on CHILD

Speaker: Dr. Meaghan Jones

Dr. Jones will discuss the epigenetic work being conducted within the CHILD Study: the progress made to date in this area, and immediate future plans.

CHILD & the Canadian Urban Environmental Health Research Consortium (CANUE)

Speaker (and session moderator): Dr. Jeffrey Brook

Dr. Brook will discuss the Canadian Urban Environmental Health Research Consortium (CANUE), which he leads, and how it is partnering with the CHILD Study to explore how multiple environmental factors in urban settings are linked to a wide range of health outcomes.